Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy

Ítems similars

• Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
  per: Cressey, Tim R., et al.
  Publicat: (2015)
• Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir boosted lopinavir on HIV viral load reduction during pregnancy
  per: Sripan, Patumrat, et al.
  Publicat: (2015)
• Early Postpartum Pharmacokinetics of Lopinavir Initiated Intrapartum in Thai Women
  per: Cressey, Tim R., et al.
  Publicat: (2009)
• Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir plus Zidovudine and Lamivudine Triple Therapy
  per: Delaugerre, Constance, et al.
  Publicat: (2009)
• COMPLIANCE WITH AND OUTCOMES OF CD4-BASED NATIONAL GUIDELINES FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV FOR THAILAND, 2006-2007
  per: Voramongkol, Nipunporn, et al.
  Publicat: (2013)